Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

NCCC Meeting 6 Agenda

Time Session
12:50–12:55 p.m.

Welcome, roll call, and review of the agenda

Linda Harris, PhD

Designated Federal Officer

Office of Disease Prevention and Health Promotion

Office of the Assistant Secretary for Health

U.S. Department of Health and Human Services

 

Clydette Powell, MD, MPH

Technical Lead

Office of Disease Prevention and Health Promotion

Office of the Assistant Secretary for Health

U.S. Department of Health and Human Services

 

William H. Herman, MD, MPH

Chair, National Clinical Care Commission

12:55–1:00 p.m.

Diabetes Prevention and Care Model

Linda Harris, PhD

Designated Federal Officer

Office of Disease Prevention and Health Promotion

Office of the Assistant Secretary for Health

U.S. Department of Health and Human Services

 

William H. Herman, MD, MPH

Chair, National Clinical Care Commission

1:00–1:20 p.m.

Achieving Health Equity and Disparities in Diabetes

Cara James, Director, CMS Office of Minority Health

Meagan Khau, Director, Data and Policy Analytics Group
1:20–1:30 p.m.

Achieving Health Equity and Disparities in Diabetes Q&A

1:30–2:05 p.m.

Medicare Coverage, Durable Medical Equipment, & Program Integrity

Beth Koller, MD, FACE, Coverage and Analysis Group

Joel Kaiser, Director, Division of Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS) Policy

Jill Nicolaisen, Senior Technical Advisor, Center for Program Integrity

Jennifer Phillips, Center for Program Integrity

2:05–2:15 p.m.

Medicare Coverage, Durable Medical Equipment, & Program Integrity Q&A

2:15–2:45 p.m.

Diabetes Self-Management Education & Training, Virtual Care, & Other Provider Types Delivering Diabetes Care      

Jennifer Lloyd, PhD, MA

Beth Koller, MD, FACE, Coverage and Analysis Group

Marge Watchorn, Deputy Director, Division of Practitioner Services

Gift Tee, Director, Division of Practitioner Services
2:45–3:00 p.m.

Diabetes Self-Management Education & Training, Virtual Care, & Other Provider Types Delivering Diabetes Care Q&A

3:00–3:15 p.m. BREAK
3:15–3:45 p.m.

Access to Part D Drugs & Formulary Review

Stephanie Hammonds, PharmD, RPh,

Robert Dombrowski, Deputy Director, Division of Formulary and Benefit Operations
3:45–4:00 p.m.

Access to Part D Drugs & Formulary Review Q&A

4:00–4:20 p.m.

Section 1115 Demonstrations, Non-Emergency Medical Transportation, Medicaid Core Set

Judith Cash, Director, State Demonstrations Group

Alissa DeBoy, Director, Disabled and Elderly Health Programs Group

Kirsten Jensen, Director, Division of Benefits & Coverage

Melissa Harris, Deputy Director, Disabled and Elderly Health Programs Group

Karen Matsuoka, Director, Division of Quality & Health Outcomes
4:20–4:30 p.m.

Section 1115 Demonstrations, Non-Emergency Medical Transportation, Medicaid Core Set Q&A

4:30–4:50 p.m.

Model Testing and the Medicare Diabetes Prevention Program   

Nina Brown-Ashford, Deputy Director, Prevention and Population Health Group

Elizabeth Mathews, Director, Division of Health Care Delivery
4:50–5:00 p.m.

Model Testing and the Medicare Diabetes Prevention Program Q&A

5:00–5:15 p.m. Oral Public Comments
5:15 p.m. Adjournment